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We	  report	  the	  solu]on	  structures	  of	  the	  VPg	  proteins	  from	  feline	  calicivirus	  (FCV)	  and	  murine	  norovirus	  (MNV),	  which	  have	  
been	  determined	  by	  nuclear	  magne]c	  resonance	  spectroscopy.	  In	  both	  cases	  the	  core	  of	  the	  protein	  adopts	  a	  compact	  
helical	  structure	  ﬂanked	  by	  ﬂexible	  N	  and	  C-­‐termini.	  Remarkably,	  while	  the	  core	  of	  FCV	  VPg	  contains	  a	  well-­‐deﬁned	  three-­‐
helix	  bundle,	  the	  MNV	  VPg	  core	  has	  just	  the	  ﬁrst	  two	  of	  these	  secondary	  structure	  elements.	  In	  both	  cases	  the	  VPg	  cores	  are	  
stabilised	  by	  networks	  of	  hydrophobic	  and	  salt-­‐bridge	  interac]ons.	  The	  Tyr	  residue	  in	  VPg	  that	  is	  nucleo]dylated	  by	  the	  viral	  
NS7	  polymerase	  (Y24	  in	  FCV,	  Y26	  in	  MNV)	  occurs	  in	  a	  conserved	  posi]on	  within	  the	  ﬁrst	  helix	  of	  the	  core.	  Intriguingly,	  given	  
its	  structure,	  VPg	  would	  appear	  to	  be	  unable	  to	  bind	  to	  the	  viral	  polymerase	  so	  as	  to	  place	  this	  Tyr	  in	  the	  ac]ve	  site	  without	  a	  
major	  conforma]on	  change	  to	  VPg	  or	  the	  polymerase.	  However,	  muta]ons	  that	  destabilised	  the	  VPg	  core	  either	  had	  no	  
eﬀect	  on	  or	  reduced	  both	  the	  ability	  of	  the	  protein	  to	  be	  nucleo]dylated	  and	  virus	  infec]vity	  and	  did	  not	  reveal	  a	  clear	  
structure-­‐ac]vity	  rela]onship.	  The	  precise	  role	  of	  the	  calicivirus	  VPg	  core	  in	  virus	  replica]on	  remains	  to	  be	  determined	  but	  
knowledge	  of	  its	  structure	  will	  facilitate	  future	  inves]ga]ons.
CALICIVIRUSES are a family of positive-sense, single-stranded 
RNA viruses that contain the Vesivirus,  Sapovirus, Lagovirus 
and Norovirus genera. They infect a wide variety of 
mammals, causing an array of different diseases. For 
example, feline calicivirus (FCV), a vesivirus, is associated 
with a range of conditions including upper respiratory tract 
disease in cats (1), while noroviruses and sapoviruses cause 
gastroenteritis.  Human noroviruses represent a major health 
problem: they are estimated to be responsible for twenty one 
million cases of gastroenteritis in the United States every year 
and 200,000 deaths among children in developing countries 
(2, 3).
The study of human noroviruses (HuNV) has been impeded 
by the absence of a viable cell culture system for this 
pathogen and the fact that baby gnotobiotic pigs are the only 
available small animal model (4, 5).  As a result other 
caliciviruses have often been used as surrogate models for the 
investigation of HuNV biology (6). FCV and murine 
norovirus (MNV) have been widely used to investigate 
general features of calicivirus replication since they both 
grow in tissue culture and have workable reverse genetics 
systems (7-11). MNV is emerging as a popular model system 
since it can cause systemic disease or gastroenteritis in 
immunocompromised mice that resemble human norovirus 
infections (12, 13).
The ~7.5 kb calicivirus genome contains 2 to 4 open reading 
frames (ORFs) depending on the genus. The major (VP1; 
ORF2) and minor (VP2; ORF3) capsid proteins of 
caliciviruses are usually translated from a sub-genomic RNA 
(as is the protein derived from ORF4 in MNV (14)).  ORF1 
encodes a large polyprotein precursor that is cleaved into 
mature non-structural proteins (NS1–NS7) by the virus-
encoded protease, NS6pro (15-18). The mature proteins 
include an RNA dependent RNA polymerase (NS7pol), an 
ATPase (NS3), as well as proteins that disrupt cellular 
trafficking (NS1-2 and NS4) (15, 19-23). 
In addition, proteolytic cleavage of the ORF1 polyprotein 
releases the NS5 protein, which is also known as VPg (Viral 
Protein genome-linked). The caliciviral VPg is a 13-15 kDa 
protein that is found covalently attached to the 5′  terminus of 
the genomic and sub-genomic RNAs (24-26). Covalently 
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attached terminal proteins are also found at the 5´ ends of the 
genomes of other positive sense RNA viruses including the 
Picornaviridae and Astroviridae, which are mammalian 
viruses, and several plant virus families, such as the 
Potyviridae,  Comoviridae and Nepoviridae. They also occur 
in DNA viruses in the Adenoviridae and in members of the 
bacteriophage Podoviridae (27-34). 
The VPg proteins of different viruses vary in size and 
sequence. For example, within the positive-sense RNA 
viruses, Comoviridae and Picornaviridae VPgs are ~3 kDa, 
the Potyviridae VPg is ~24 kDa, and the Calicivirus VPg is 
13-15 kDa.  The calicivirus VPg proteins are more similar to 
the VPgs found in Astroviridae, which are predicted to be 
around 11 kDa in size and have 20-27% amino-acid sequence 
identity with their calicivirus counterparts (31). 
VPg is essential for translation initiation from genomic and 
sub-genomic RNAs and appears to act as a cap substitute for 
ribosomal recruitment (11, 26). The molecular basis for this 
function is now emerging. The VPg proteins from both FCV 
and MNV have been found to interact with the cap binding 
protein eIF4E (35, 36). In addition, an interaction has been 
demonstrated between HuNV VPg and purified eIF3 complex 
(37). These studies suggest that VPg may recruit the ribosome 
to the genomic RNA through interaction with the canonical 
translation initiation factors. A similar role has also been 
described for the VPg proteins from the Nepoviridae and 
Potyviridae (38-41).  Moreover, the observations that protease 
K treatment to remove VPg from astrovirus RNA renders the 
viral RNA non-infectious and that infectivity can be restored 
to RNA transcripts by addition of a 5´ m7G cap are consistent 
with a role for astroviral VPg in translation (31, 42). 
VPg is also important for genome replication. The caliciviral 
VPg can be nucleotidylated by the viral polymerase via a 
phosphodiester linkage to a conserved tyrosine residue (43) 
— Y24, Y26 and Y27 in the VPg of FCV, MNV and human 
norovirus (HuNV), respectively (43-45).  Nucleotidylated 
VPg can be extended in a template-dependent manner to 
produce RNA-linked VPg (46). While the mechanism of 
caliciviral RNA replication has not been fully characterised, it 
is likely that VPg becomes covalently attached to the genomic 
RNA by acting as a primer for positive-strand RNA synthesis. 
Yeast two-hybrid data also suggest that the FCV VPg protein 
interacts with the major capsid protein VP1, indicative of a 
possible role in the selective encapsidation of VPg-linked 
viral RNA (47).
The solution structures of the 22 amino-acid VPg from 
poliovirus,  a picornavirus,  has been determined using nuclear 
magnetic resonance (NMR) spectroscopy for both the native 
peptide and VPg that has been nucleotidylated on its acceptor 
Tyr 3 residue (48, 49). In its native form poliovirus VPg 
appears to be highly flexible; a defined conformation was 
observed only in the presence of high concentrations (1 M) of 
the organic solvent trimethylamine N-oxide (TMAO). 
Intriguingly, the nucleotide-linked poliovirus VPg-pU 
appeared more stable and exhibited a defined, globular 
conformation in an aqueous solution that lacked TMAO (49). 
However, the physiological relevance of this structure is 
uncertain; although the poliovirus VPg-pU structure could be 
computationally docked with the viral 3D polymerase, the 
resulting model did not position the uridine in VPg close 
enough to the active site residues of the polymerase to 
plausibly account for the nucleotidylation reaction. Moreover, 
this model does not take into account the conformational 
changes that might be induced by association with the 
polymerase and is inconsistent with the extended 
conformation of VPg-pU observed in the crystal structure of 
the 3Dpol:VPg-pU complex for the closely related 
picornavirus, foot-and-mouth disease virus (FMDV) (50). 
Both the potyviral and noroviral VPgs have been predicted to 
be largely disordered (51). In the case of potyviruses circular 
dichroism and thermal stability measurements and tryptic 
digest assays all pointed to the presence of some structured 
elements within the protein (52-54). But although NMR 
analyses have detected several aromatic shifted methyl peaks 
in 1D and 1H-13C HSQC spectra for potyvirus VPg, 
suggesting that the protein is at least partially folded (54),  it is 
commonly regarded as ‘intrinsically disordered’(55).
We report here the determination of the solution structures of 
two calicivirus VPgs using NMR spectroscopy. We find that 
the FCV and MNV VPg proteins both possess a compact 
helical core that is flanked by unstructured N and C-terminal 
tails.  Intriguingly, the MNV VPg core only contains the first 
two of the three helices present in the core of FCV VPg. For 
both proteins the nucleotidylated Tyr residue projects into 
solvent from the centre of the first helix in the protein core. 
The core structure facilitated the design of mutagenesis 
experiments to investigate the role of the protein structure in 
RNA replication and infectivity. The results showed that 
mutations that disrupt the fold of the helical core generally 
impair the ability of VPg to support virus replication and 
nucleotidylation by the MNV VPg.  The structured core 
therefore appears to be functionally important for interaction 
with the MNV RdRp. 
Materials	  and	  Methods
VPg cloning and expression – MNV VPg 11-62, 11-85 and 1-124 
(full length) were amplified from the MNV-1 infectious clone 
pT7:MNV 3’Rz (NCBI accession DQ285629.1) and ligated into the 
expression vector pETM11 (8, 56). FCV VPg 1-111 (full  length) was 
amplified from a full length FCV VPg clone of the F9 strain (NCBI 
accession M86379) and ligated into pETM11. FCV VPg 9-79 was 
amplified from the same template and ligated into the expression 
vector pQE30 (Qiagen). Both pQE30 and pETM11 encode 
Nterminal 6x-histidine tags. Processing of proteins expressed from 
the pETM11 vector with TEV NIa protease removed the tag leaving 
GAM and G residues on the N-termini of MNV and FCV VPg 
respectively. The pQE30 vector adds a noncleavable polyhistidine 
tag (MRGSHHHHHHGS) to the N-terminus of the expressed 
protein. 
QuikChange mutagenesis (Stratagene) was performed on pETM11 
FCV VPg 1111 and MNV VPg 1124 constructs to produce the 
following mutants for NMR analyses: FCV VPg Y24A, F43A, 
R47E, F62A and R69E; and MNV VPg Y26A, Y26F, F29A, R32D, 
Y40A, Y40F, Y45A, Y45F, D48R and the R32D/D48R double 
mutant. The sequences of primers used for mutagenesis can be found 
at http://dx.doi.org/10.6084/m9.figshare.155873. 
All isotopically-labelled MNV VPg proteins were expressed in E. 
coli (DE3) Rosetta cells for 1618 hours at 20°C by addition of 
Isopropyl β-D-thiogalactopyranoside (IPTG) to  a final concentration 
of 1 mM. The MNV VPg 11-85 construct used for structure 
determination was expressed using E. coli OD 2 13C, 15N rich media 
(Silantes), whereas 15N labelled MNV VPg 1-124 and 11-62 were 
expressed in minimal media containing 0.2% w/v 15NH4Cl. 
FCV VPg 1-111 protein for backbone assignment and 1H-15N 
heteronuclear nuclear Overhauser effect  (hetNOE) analysis was 
expressed in E. coli BL21 (DE3) cells for 4 hours in E. coli OD 1 
13C15N rich media (Silantes) at 22°C with 1 mM final IPTG. The 
FCV VPg 11-79 protein for the structure determination was 
expressed overnight  in E. coli M15 in  minimal media containing 
0.1% w/v 15NH4Cl  and 0.4% w/v 13C6 glucose at  18°C with 0.5 mM 
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final IPTG. Unlabelled MNV VPg 1-124 and FCV VPg 1-111, and 
mutant variants of these proteins used in 1D NMR experiments were 
produced in E. coli (DE3) Rosetta cells for 4 hours in lysogeny broth 
(LB) (57) at 20°C by addition of 1 mM IPTG. 
Protein purification – Isotopically-labelled  MNV VPg proteins 
were purified  by affinity chromatography using TALON resin 
(Clontech). The polyhistidine tag was then removed by overnight 
incubation with  approximately 1 mg of polyhistidine-tagged TEV 
NIa protease per 15 mg of VPg in a buffer typically made up of 50 
mM sodium phosphate pH 6.5, 300 mM NaCl and 1 mM DTT. TEV 
NIa protease and cleaved tags were removed from VPg by re-
application of the cleaved VPg to TALON. Final purification of 
MNV VPg 11-85 for the structure determination, and MNV VPg 
1-124 used in NaCl, pH and temperature titrations was performed by 
size exclusion chromatography on an S75 16/60 column (GE 
Healthcare) with a buffer containing 50 mM sodium phosphate pH 
6.5, 300 mM NaCl, 1 mM DTT. 
FCV VPg 1-111 used in  backbone assignments and  hetNOE analysis 
was purified using the same protocol as described above for MNV 
VPg 11-85. FCV VPg 9-79 was purified by one-step affinity 
chromatography to Ni-NTA agarose resin (Qiagen). MNV VPg 
1-124 and FCV VPg 1-111 and mutant proteins for use in 1D NMR 
were purified  by one step affinity chromatography using TALON 
resin.
MNV and FCV VPg assignment and structure determination – 
All NMR spectra were recorded on Bruker 500, 600  or 800 MHz 
spectrometers. Backbone assignments of FCV VPg 1-111 were 
obtained using the following 3D heteronuclear experiments:  HNCA, 
C B C A ( C O ) N H , H N C A C B , H N C O , H N ( C A ) C O , 
HBHA(CBCACO)NH and 1H-15N NOESY (NNOESY) HSQC. 
Additionally, hetNOE data for FCV VPg 1-111 were recorded. All 
these experiments were done using FCV VPg at a concentration of 
0.5-1.0 mM in buffer composed of 50 mM sodium phosphate pH 
6.5, 200 mM NaCl, 1  mM EDTA, 1 mM NaN3, and 1 mM β-
mercaptoethanol, at  298 K. Data were analysed using NMRView 
version 4.1.3 (One Moon Scientific).
For both MNV VPg 11-85 and FCV VPg 9-79, the proteins used in 
structure determination, backbone and aliphatic side chain 
assignments were completed using an in-house NMRview based 
assignment protocol (58). This was initially used in  combination 
with  MARS to establish sequential  connectivity, after which 
assignments were completed (59). The experiments used in the 
backbone assignment were HNCACB, CBCA(CO)NH, HNCO, 
HN(CA)CO. Aliphatic side chain assignment was primarily 
completed using the HBHA(CBCA)NH, H(C)CH TOCSY and the 
(H)CCH TOSCY experiments; in addition, the H(CC)(CO)NH and 
(H)CC(CO)NH TOCSY experiments were used in MNV VPg 11-85 
for these assignments. Aromatic side chain assignments  were made 
primarily using NOE correlation of aromatic side groups to the 
assigned Hβ and an aromatic 1H-13C HSQC. In addition 
(HB)CB(CGCD)HD and (HB)CB(CGCDCE)HE experiments  were 
used in the MNV VPg 11-85 aromatic assignment. NOE distance 
restraints were derived using the NNOESY HSQC and 1H-13C 
NOESY (CNOESY) HMQC experiments. NOESY mixing times for 
FCV and MNV proteins were 100 ms and 125 ms respectively. In  all 
structure determination experiments FCV VPg 9-79 was at a 
concentration of 100-200 µM in 20 mM HEPES pH 7, 
300 mM NaCl, 1 mM NaN3. MNV VPg 11-85 was at a concentration 
of 590 µM in  50 mM sodium phosphate pH 6.5, 300 mM NaCl, 1 
mM DTT, for all but the 1H-13C NOESY-HMQC, H(C)CH-TOCSY, 
(H)CCH-TOSCY, (HB)CB(CGCD)HD, and (HB)CB(CGCDCE)HE 
experiments. For these experiments  the protein was at 710 µM in 60 
mM sodium phosphate pH 6.5, 360 mM NaCl, 1 mM DTT, 0.1% w/
v NaN3 and 1x cOmplete protease inhibitor cocktail (Roche). 
Despite buffer differences, the NOESY and side chain experiments 
recorded in different  buffers correlate very well with  each other. 
Experiments on MNV VPg 11-85 and FCV VPg 9-79 were recorded 
at 303 K and 283 K respectively. 
NOEs were assigned and structures calculated using the ARIA 
protocol and CNS including a final water refinement (60-62). 
TALOS+ was used to generate dihedral angle restraints that  were 
also implemented in the structure calculation (63). In the case of 
FCV VPg 9-79 1H-15N Residual Dipolar Coupling (RDC) restraints 
were also applied. IPAP (In-Phase/Anti-Phase) 1H-15N HSQC spectra 
were recorded in conditions described previously and with  15 mg/ml 
PF1 filamentous  phage as  alignment  media (ASLA biotech). Model 
validation of FCV and MNV VPg structures was performed using 
PSVS (64). 
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Figure 1: 1H-15N HSQC and hetNOE data for FCV and MNV 
VPg proteins. (A) 1H-15N HSQC spectrum for FCV VPg. (B) 
1H-15N hetNOE measurements for full-length FCV VPg plotted 
against residue number. The gap in the data corresponds to amides 
from residues 26-38 inclusive, which could not be assigned from 
data collected at 298 K. (C) 1H-15N hetNOE measurements for 
MNV VPg full length (1-124) (filled diamonds) and MNV VPg 
11-85 (open squares). The backbone amides of residues 1-10 and 
86-124 were not assigned.
Validation of the MNV VPg structure – 1H-15N HSQC spectra of 
MNV VPg 1-124 and 11-62 for structure validation purposes were 
recorded at 240 µM and 550 µM protein concentrations respectively 
in  50 mM sodium phosphate pH 6.5, 300 mM NaCl and 1 mM DTT. 
These experiments  were performed at 303 K and compared to the 
reference 1H-15N HSQC of MNV VPg 11-85 obtained using 590 µM 
protein in 50 mM sodium phosphate pH 6.5, 300 mM NaCl, 1 mM 
DTT. Heteronuclear NOE experiments were performed using both 
MNV VPg 11-85 and MNV VPg 1-124 at concentrations of 590 µM 
and 420 µM respectively. The buffer conditions were as per the 
MNV VPg 1-124 1H-15N HSQC with the exception that  0.1% NaN3 
and 1x cOmplete protease inhibitor cocktail were present in the VPg 
11-85 sample. 
1D NMR of VPg mutants  – The 1D NMR spectra of wild-type and 
mutant MNV VPg 1-124 proteins  were typically recorded at 298 K 
in  50 mM Tris  pH 7, 300 mM NaCl, 2 mM β-mercaptoethanol. 
These conditions were also used for FCV VPg 1-111 and mutants 
thereof with the exception that 150 mM NaCl was used. The protein 
concentration used was ~45 µM for FCV VPg and between 90 and 
170 µM for MNV VPg.
MNV and FCV viability assays — For FCV, the QuikChange II 
XL Site-Directed Mutagenesis Kit (Agilent Technologies, Inc.) and 
set of mutagenic primers were used to modify  the FCV full-length 
cDNA clone pQ14 (11) to  introduce amino acid changes into the 
FCV VPg sequence at positions 30 (H to  A, I), 43 (F to A), 47 (R to 
E, G), 62 (F to A), 65 (W to A), 66 (W to A) and 69 (R to E). The 
modified clones were screened by  sequencing, and plasmids 
containing desired mutations were selected for further experiments. 
The recovery of infectious FCV from the selected full-length cDNA 
clones was conducted using capped in vitro transcribed RNA as 
described previously (11, 65) but with the minor modification of 
using enzymatically capped RNA transcripts as described (9). CRFK 
(Crandell-Rees Feline Kidney) cells were transfected with capped 
genomic RNA transcripts synthesized from the corresponding 
plasmid DNA templates  by in vitro transcription using T7 RNA 
polymerase. Cells were transfected with 1  µg of RNA using 
Lipofectamine 2000 (Invitrogen) and incubated at 37 °C for 24 h. 
Cells were freeze-thawed at -80°C to release virus particles  and viral 
titre was determined using TCID50 on CRFK cells. 
For MNV, mutations in VPg were introduced by overlapping PCR 
mutagenesis, with the mutagenised region being inserted back  into 
the MNV-1 full length infectious clone pT7:MNV 3´Rz. The 
complete sequence of the mutagenised region was determined in all 
cases prior to use. The effect  of the various VPg mutations on virus 
recovery was  determined using the reverse genetics system based on 
recombinant Fowlpox expressing T7 RNA polymerase as previously 
described (8). Briefly, BSRT7 cells were infected with fowlpox virus 
expressing T7 RNA polymerase (based on the virus titre in chick 
embryo fibroblasts) at an m.o.i of 0.5 p.f.u. per cell. After 2 h, 1 µg 
of each MNV cDNA construct was transfected using Lipofectamine 
2000 according to the manufacturer’s instructions. At 24 h post-
transfection of DNA, the cells were freeze-thawed at -80 °C to 
release virus particles and viral titre was determined using TCID50 
on  RAW264.7 cells. In all cases, the expression of the viral RNA 
polymerase NS7 24 hours post transfection of the cDNA construct 
was  analysed by western blot to  confirm equal transfection 
efficiency. 
VPg-RNA synthesis assays — The MNV RdRp and VPg coding 
regions were amplified using PCR from the MNV-1 infectious clone 
pT7:MNV 3’Rz (GenBank accession  number DQ285629.1) and 
cloned into the pUNO vector (InvivoGen, San Diego, CA). All VPg 
mutants were generated using specific forward and reverse primers 
and QuikChange mutagenesis kit  (Agilent Technologies). All 
plasmid constructs were confirmed by DNA sequencing using the 
BigDye Terminator v3.1 cycle sequencing kit (Applied Biosystems). 
The NoV-5BR assay was used to determine the efficiency of RNA 
synthesis  (44).  In this assay, HEK293T cells were transiently 
transfected with plasmids to express the NoV RdRp and the 
components needed to detect the RNAs produced by the NoV 
polymerase and, where appropriate, with VPg. The RNAs 
synthesized by the NoV RdRp activate signal transduction by the 
innate immune receptor, RIG-I, which leads to expression of the 
Firefly luciferase reporter that is under the control of the IFN-β 
promoter. The cells also express  the Renilla luciferase under the 
control of a constitutive promoter to monitor transfection efficiency 
and cytotoxicity. Briefly 1x105 HEK 293T cells  were seeded in a 
Costar 96 well plate with DMEM and 10% fetal bovine serum for 24 
h prior to co-transfection of the plasmids that can express VPg, 
NS7pol, RIG-I, and the two reporter luciferases.  36 h post 
transfection, luciferase levels were determined using the Dual-Glo® 
Luciferase Assay System (Promega) and a Synergy 2 microtiter plate 
reader (BioTek). RNA synthesis efficiency is reported as the ratio of 
Firefly to Renilla luciferase activities. 
A VPg-RNA electrophoretic mobility  shift  assay (EMSA) was used 
to  determine whether the NoV RdRp used VPg as a protein primer 
for RNA synthesis. HEK293T cells (1.0 x 106/ ml in 6-well  plates 
[BD Falcon]) were transfected with HA-tagged WT or mutant MNV 
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Figure 2: Solution structure of  FCV VPg 9-79. (A) Backbone trace of the twenty lowest-energy conformers of FCV VPg 9-79 calculated 
using ARIA (60) and  CNS (61) including a final  water refinement. The nucleotide accepting tyrosine (Y24) side chain of one of the models 
is  shown. (B) A representative conformer of FCV VPg 9-79 with selected (mainly hydrophobic) side chains shown as sticks and coloured by 
atom type (carbon – tan; oxygen – red; nitrogen – blue). The N and C-termini are indicated. (C) FCV VPg 9-79 rotated by 180° compared to 
panel B and with key charged and polar residues involved in  electrostatic interactions shown as sticks. Salt bridges are indicated by dashed 
black lines.
VPgs along with FLAG-tagged NS7pol 24 hours post-transfection, 
VPg and VPg-RNA were immunoprecipitated  using anti-HA 
polyclonal antibody covalently linked to Dynabeads M-270 epoxy 
resin and were resolved on a 4-12% NuPAGE Novex Bis-Tris gel 
and morpholinepropanesulfonic acid-SDS running buffer 
(Invitrogen) and transferred to a PVDF membrane which was then 
probed with anti-HA antibodies to detect VPg (44). 
Protein structure accession numbers: Coordinates and NMR data 
have been deposited with the Protein Data Bank. The accession 
numbers are 2M4G (MNV VPg 11-85) and 2M4H (FCV VPg 9-79).
Results
Solution structure of FCV VPg – Given previous reports of 
the intrinsically disordered nature of VPg proteins, we sought 
first to determine whether FCV VPg contained structured 
regions by analysing a 1H-15N HSQC spectrum. The 
dispersion of amide peaks evident in the spectrum recorded 
for full-length FCV VPg (residues 1-111) indicated that the 
protein was at least partially structured (Fig. 1A). To define 
the structured portions of the protein,  peaks in the spectrum 
corresponding to backbone amides were assigned (see 
Materials and Methods). Backbone amide assignments were 
made for 98 of the 111 residues; curiously, the 13 peaks 
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Table	  1:	  Summary	  of	  NMR	  data	  and	  model	  calcula]on	  sta]s]cs
Restraints MNV	  VPg	  11-­‐85 FCV	  VPg	  9-­‐79
Total	  number	  of	  Restraints 1248 1335
NOE-­‐derived 1176 1172
Unambiguous	  NOE	  restraints 618 867
Ambiguous	  NOE	  restraints 558 305
Intra-­‐residual	  NOE	  restraints	  (|i-­‐j|=	  0)a 262 373
Sequen]al	  	  NOE	  restraints	  (|i-­‐j|=	  1) 106 197
Medium	  range	  NOE	  restraints	  (1<|i-­‐j|≤	  4) 140 153
Long	  range	  NOE	  restraints	  (|i-­‐j|>4) 110 144
Ψ/Φ	  dihedral	  angle	  restraints 72 84
HN	  RDC	  restraints -­‐ 37
Hydrogen	  bond	  restraints -­‐ 42
RMSD	  from	  experimental	  restraintsa
Distance	  (Å) 0.032	  +/-­‐	  	  0.001 0.057	  +/-­‐	  0.002
Dihedral	  angle	  (°) 0.16	  +/-­‐	  	  0.07 0.755	  +/-­‐	  0.13
NOE/Dihedral	  violaMons
NOE	  viola]ons	  >	  0.5	  Å 0 0.4	  +/-­‐	  0.5
NOE	  viola]ons	  >	  0.3	  Å 0.60	  +/-­‐	  0.66 	  4.55	  +/-­‐	  1.6
Dihedral	  viola]ons	  >	  5° 0 0
RMSD	  from	  idealised	  covalent	  geometrya
Bond	  (Å) 0.0038	  +/-­‐	  0.0001 0.0058	  +/-­‐	  0.0002
Angle	  (°) 0.48	  +/-­‐	  0.01 0.76	  	  +/-­‐0.02
Impropers	  (°) 1.15	  +/-­‐	  0.06 2.01	  +/-­‐	  0.08
Energiesa	  (kcal/mol)
Etotal -­‐2673.45	  +/-­‐	  86.02 -­‐2047.8	  +/-­‐71.2
ENOE 59.98	  +/-­‐	  1.84 198.4	  +/-­‐	  15.1
Ebond 17.74	  +/-­‐	  1.38 	  36.6	  +/-­‐	  2.4
Eangle 78.53	  +/-­‐	  4.10 	  165.8	  +/-­‐	  10.9	  
Evdw -­‐626.53	  +/-­‐	  6.15 	  -­‐655.0	  +/-­‐	  7.0
Coordinate	  RMSDa	  (Å)
Backbone	  atoms	  in	  secondary	  structure 0.32	  +/-­‐	  0.1 0.17	  +/-­‐0.03
All	  heavy	  atoms	  in	  secondary	  structure 0.81	  +/-­‐	  0.1 0.54	  +/-­‐	  0.1
All	  backbone	  atoms 6.61	  	  +/-­‐	  1.8 0.36	  +/-­‐	  0.1
All	  heavy	  atoms	   7.12	  +/-­‐	  1.8 0.66	  +/-­‐	  0.1
Ramachandran	  plotb,c,d
Most	  favoured	  (%) 99.6 82.3
Allowed	  (%) 0.4 14.4
Disallowed	  (%) 0 3.3
PDB	  ID 2M4G 2M4H
Structure	   sta]s]cs	  for	  MNV	  VPg	   11-­‐85	  and	  FCV	  VPg	   9-­‐79.	  Averages	  are	   given	  +/-­‐	  one	  standard	  devia]on	  of	   the	  mean.	  ai	   and	   j	   are	   residue	  numbers	  in	  the	  
VPg	  polypep]de.	  bDetermined	  with	  an	  ensemble	   of	   	  the	   lowest	  energy	   20	  structures	  which	  were	   water	  reﬁned.	  cRamachandran	  sta]s]cs	  calculated	  using	  
Molprobity	  (65).	  dThese	  were	  calculated	  using	  the	  core	  domains	  of	  the	  proteins	  as	  determined	  by	  Molprobity	  (MNV	  VPg	  21-­‐55	  and	  FCV	  VPg	  17-­‐73).
missing from the spectrum corresponded to a contiguous 
portion — residues 26 to 38 — of the VPg sequence. 
1H-15N hetNOE measurements were used to determine the 
dynamics of each backbone amide group on a picosecond-
nanosecond timescale.  The assigned amides for residues 
12-72 had hetNOE values greater than 0.5, indicative of a 
structured domain (Fig. 1B). Outside this region hetNOE 
values were close to or less than zero, revealing that the N-
terminal 11 residues and the C-terminal 39 residues of the 
protein are more mobile. FCV VPg thus appears to possess a 
structured core flanked by flexible termini.  As a result of 
these initial characterizations, a construct that expressed FCV 
VPg 9-79 was generated for solution structure determination. 
A protein containing residues 9-79 of the FCV VPg was 
analyzed by 1H-15N HSQC at 298 K and was also found to 
lack signals corresponding to backbone amides for residues 
26-38. The absence of peaks associated with this region of the 
protein is likely due to local conformational exchange at 
millisecond to microsecond time scales. To attempt to move 
these dynamics out of the intermediate exchange regime, we 
recorded NMR data at reduced temperatures (down to 278 K). 
Under these conditions additional peaks were observed in 
1H-15N HSQC spectra that permitted the assignment of all the 
missing residues from 2638 apart from R34. All subsequent 
NMR analyses of FCV VPg 979 were performed at 283 K 
(see Materials and Methods); although the lower temperature 
reduced the signal-to-noise ratio in these experiments a 
reliable structure of FCV VPg 9-79 was obtained. The twenty 
final water refined conformers with lowest energy have a 
backbone RMSD (root mean square deviation) of 0.17 Å 
(Fig. 2A). A full set of structure determination statistics is 
given in Table 1.
This structural analysis of FCV VPg 9-79 revealed a compact 
core domain (residues 14-76) that is largely composed of a 
three-helix bundle (Fig.  2B, C).  Residues 22-34, 40-52 and 
57-70 make up helices α1, α2 and α3, respectively, and are 
connected by short loops that allow α2 and α3 each to pack at 
approximately right angles to the preceding helix.  The tightly 
packed helical bundle at the core of FCV VPg is stabilised by 
an extensive hydrophobic core consisting of residues V17, 
L19, W27, L36,  L38, V40, F43, L44, L46, F62, W65 and 
W66 (Fig. 2B). Residues 10-19 at the N-terminal end of the 
core form a tight turn that packs against helix α2. 
Determination of the solution structure of MNV VPg – 
The FCV and MNV VPg proteins used in this work share 
27% identity overall and 40% identity in their N-terminal 
halves (12) (Fig. 3A).  The relatively high level of sequence 
similarity between them and the structural insights from the 
FCV VPg led us to design an MNV VPg 11-85 construct that 
was predicted to correspond to the structured core of the FCV 
VPg (Fig. 3A). 
The 1H-15N HSQC spectrum of MNV VPg 11-85 exhibited 
good dispersion (Fig. 3B), indicative of a defined structure, 
but did not have the conformational exchange issues 
encountered with FCV VPg. Therefore the sample was 
analysed at 303 K to optimise the signal-to-noise ratio. A 
good quality structure was obtained for MNV VPg 11-85, 
which had a backbone RMSD of 0.32 Å for the ordered 
residues in the 20 lowest-energy structures (residues 21 to 55 
inclusive) (Fig. 4A).  Full structure-determination statistics are 
in Table 1. 
Strikingly, the MNV VPg core domain contains only two 
helices, formed by residues 23-35 and 42-55 (Fig. 4B). These 
overlay well with the first two helices in the FCV VPg 
structure (backbone RMSD 2.0 Å) (Fig. 4C).  The third helix 
observed in the FCV core structure is absent from MNV 
VPg 1185; instead residues 56-85 of the MNV VPg adopt an 
extended conformation that varies in position in all of the 
final conformers.
Validation of the two-helix  model of the MNV VPg core – 
The absence of the third helix in the core of MNV VPg was 
unexpected,  particularly since the MNV VPg protein is 
significantly larger than that of FCV VPg. To confirm the 
absence of this helix,  we compared 1H-15N HSQC spectra of 
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Figure 3: NMR analysis of the MNV VPg benefitted from 
knowledge of  the structure of  FCV VPg. (A) Amino acid sequence 
alignment of FCV and MNV VPg proteins performed using 
ClustalW. Positions of the helices detected through structural 
analysis are indicated as shaded boxes  above and below the 
sequences (green for FCV and brown for MNV). Dashed  lines 
indicate disordered portions of the polypeptide backbone. The 
nucleotidylated Tyr in each sequence is shown in bold-face. Within 
the alignment, the *, :  and . characters  denote identical, very similar 
and similar amino acids. (B) Overlay of 1H-15N HQSC spectra of 
MNV VPg constructs used to probe the extent of the structure core 
of the protein:  VPg 11-85 (blue), VPg 1-124 (black) and VPg 11-62 
(red). 
MNV VPg 11-85 with those obtained from MNV VPg 1-124 
(full length) and MNV VPg 11-62, the latter being a construct 
truncated to contain just the two-helix core. The amide signals 
from the core two-helix domains of all three proteins were 
found to overlay closely (Fig. 3B). Moreover, in comparison 
to the spectrum for MNV VPg 11-62 there were no additional 
backbone 1H-15N signals outside the centre of spectrum (in 
the proton dimension) observed for MNV VPg 1-124. These 
observations are consistent with the two-helix structure for 
MNV VPg. 
Further support for the observed structure is found in the 
hetNOE data for MNV VPg 1-124 and VPg 11-85, which 
show that helices α1 and α2 in MNV VPg are rigid: the 
hetNOE values of this region of ~0.65-0.8 strongly indicate 
that the two helices have a stable tertiary structure (Fig. 1C). 
In contrast, the region that aligns to helix α3 of FCV VPg has 
much lower hetNOE values (~0.2), indicative of significantly 
greater mobility than the preceding two helices. It is possible 
that residues in the MNV VPg corresponding to helix α3 of 
the FCV VPg has residual structural propensity that was not 
captured under our NMR conditions. To test this notion, 
1H-15N HSQC spectra were recorded over a range of pH 
values,  NaCl concentrations, and temperatures to probe their 
effects on the structure of the protein. MNV VPg 1-124 
spectra recorded at pH 4, 5,  6, 7 and 8 showed that, although 
the protein appears to be unfolded at pH 4, in the pH range 
5-8 there are no significant changes in the spectra, consistent 
with a stable structure (Fig. 5A-C). Similarly, 1H-15N HSQC 
spectra recorded from MNV VPg 1124 in buffer containing in 
50, 150 or 300 mM NaCl (pH 6.5) were almost identical 
(Fig. 5D-F). Finally, no significant changes in 1H-15N spectra 
were recorded from MNV VPg 11-85 at 278 K, 283 K, 288 K, 
293 K, 298 K or 303 K; the only notable spectral changes 
were due to the well-documented temperature-dependence of 
the amide 1H chemical shift (66). The close similarity of 
spectra recorded at 278, 288 and 303 K (Fig. 5G-I) strongly 
suggests that at the structure of MNV VPg 11-85 does not 
significantly change over this temperature range. We conclude 
that the absence of helix α3 from MNV VPg is unlikely to be 
an artifact of the conditions in which NOESY experiments 
were recorded.  
Correlating VPg structure to function – The nucleotide 
acceptors of FCV and MNV VPg proteins, Y24 and Y26 
respectively (44, 45), are located towards the N-terminal end 
of helix α1 in both molecules (Fig. 4C). This observation 
raises the question of how VPg interacts with the polymerase 
to mediate the nucleotidylation reaction because the 
structured core of VPg (approximately 20 Å x 20 Å x 30 Å 
for MNV) appears too large to fit within the enclosed 
substrate-binding channel in the calicivirus NS7 polymerase, 
which has a minimum dimension of about 12 Å (23, 67-69). It 
seems likely therefore that either VPg or NS7pol (or both) 
undergoes a significant conformational change in order to 
form a complex that is competent for nucleotidylation.  
To probe whether some relaxation of the VPg structure might 
be necessary for its function, we introduced destabilising 
mutations into VPg and examined their effect on the folded 
state and activity of the protein. In the first phase of these 
experiments we determined the destabilising effects of 
mutation in full-length MNV VPg using 1D 1H NMR. 
Mutants F29A, Y40A and Y45A were found to be severely 
destabilised, as indicated by disappearance of almost all the 
structured amide signals from the NMR spectrum (Fig. 6A). 
The structurally more conservative mutation Y40F restored 
some but not all of the missing amide peaks, indicative of a 
lesser degree of destabilisation compared to the alanine 
substitution. In the case of the Y45F mutation the spectrum is 
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Figure 4: Solution structure of MNV VPg 11-85. (A) Backbone trace of the twenty lowest-energy conformers of MNV VPg 11-85 
calculated by ARIA (60) and CNS (61). The side chain of the nucleotide-accepting tyrosine from one of the conformers is indicated. (B) A 
representative conformer of MNV VPg 11-85. The N and C-termini are indicated. (C) Overlay of the structured cores of FCV VPg (tan) 
and MNV VPg (green);  the backbone RMSD between the two structures is  ~ 2 Å. (D) A representative conformer of MNV VPg 11-85 with 
selected (mainly hydrophobic) side chains shown as sticks and coloured by atom type. (E) MNV VPg 11-85 rotated by 110° compared to 
panel D and with key charged and polar residues involved in electrostatic interactions shown as  sticks. Polar interactions are indicated by 
dashed black lines.
very similar to that of wild-type protein. The greater 
disruption observed for Y40F may be attributable to the role 
of the Y40 hydroxyl group in stabilising the guanidinium 
group of R32 in wild-type MNV VPg (Fig. 4E). By contrast 
to the effects of non-conservative mutation of buried Tyr 
residues, substitution by alanine of the solvent-exposed side 
chain of Y26 (the nucleotide acceptor) did not significantly 
affect the structured amide signals visible in 1D 1H NMR 
spectrum.
We also probed the ability of charged residues observed to be 
involved in electrostatic interactions on the stability of the 
MNV VPg core. Mutants R32D and D48R that should contain 
a disrupted inter-helical salt bridge (Fig. 4E) had fewer 
structured amides in the NMR spectrum but appeared to 
retain some residual core structure (Fig. 6A). An attempt to 
restore this salt bridge using a R32D/D48R double mutant did 
not stabilise the VPg core. This is perhaps not surprising 
given that R32 is also stabilised by interaction with the 
hydroxyl of Y40 (Fig. 4E). 
For FCV VPg, F43A and F62A mutations were introduced to 
destabilise the hydrophobic core while R47E and R69E were 
introduced to disrupt electrostatic interactions between helix 
α1 and helix α2 and between helix α1 and helix α3 
respectively. The structured amide region of wild-type FCV 
1-111 spectrum has only 5 amide peaks as markers of 
structure, but the spectra of the F43A and R47E mutants 
lacked these peaks, indicative of a large disruption to the 
protein structure (Fig. 6B).  F62A and R69E retain only one of 
these peaks suggestive of a core with some residual structure. 
As with MNV VPg, mutation of the nucleotide accepting 
tyrosine, Y24, provided a useful negative control: the Y24A 
substitution resulted in a spectrum that is very similar to wild-
type FCV VPg.
Having examined their effects on VPg stability, we next 
sought to determine whether these mutations affected the 
ability of MNV VPg to interact with the RdRp and to be 
nucleotidylated. At the same time we also aimed to define in 
greater detail the regions in the MNV VPg needed for 
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Figure 5: Effects of  pH, NaCl and temperature on the 1H-15N HSQC spectrum of  MNV VPg 1124. Spectra recorded for MNV 
VPg 1-124 at (A) pH 5, (B) pH 6 and (C) pH 7. The spectra was recorded at 303 K with 100 µM protein dissolved in  50 mM MMT (Malic 
acid, 2-(N-morpholino)ethanesulfonic acid (MES) and Tris-HCl at  a molar ratio of 1:2:2), 300 mM NaCl, 1 mM DTT which was titrated to 
the required pH with HCl or NaOH as appropriate. (D-F) 1H-15N HSQC spectra recorded at 303 K with 40 µM protein in 50 mM sodium 
phosphate pH 6.5, 1 mM DTT supplemented with (D) 50 mM NaCl, (E) 150 mM NaCl or (F) 300 mM NaCl. (G-I) 1H-15N HSQC spectra 
recorded with 590 µM protein in 50 mM sodium phosphate pH 6.5, 300 mM NaCl, 1 mM DTT at (G) 278 K, (H) 293 K and (I) 303 K. 
functional interaction with the viral polymerase.  In the 
absence of an in vitro nucleotidylation assay for FCV or 
MNV VPg that recapitulates the specificity observed during 
infection (70), the functional VPg-RdRp interaction was 
monitored using a transient transfection assay that detects 
MNV polymerase activity (44). In this assay, the RNAs 
synthesized by the MNV RdRp serve as agonists for the 
innate immune receptor, RIG-I, activation of which leads to 
Firefly luciferase reporter expression from a beta interferon 
promoter (44). Importantly, co-expression of the wild-type 
MNV VPg with the MNV polymerase was found to increase 
luciferase production by about 40 to 50% (71).  
An extensive panel of MNV VPg mutations was tested in the 
assay, with an emphasis on residues located in the core 
(Fig. 7). Mutations in the unstructured N (K3A, K5A, K7A) 
and C-termini (V115A, D116A, Y117F) did not significantly 
impair the ability of VPg to enhance RNA synthesis. In 
contrast,  substitution of amino acids within the highly 
conserved 21LTDEEYDE28 motif that contains the nucleotide 
acceptor (Y26) (Fig. 3A) all reduced the ability of the VPg to 
stimulate RdRp activity (see bar graph in Fig. 7).
Mutation of Y40 and Y45, residues that contribute to the 
stability of the core, had variable effects (Fig. 7). Although 
Y40A and Y45A are both largely destabilising, VPg 
containing Y40A could not synthesize VPg-RNA and nor did 
Figure 6: Effects of  site-directed mutations on the stability of  the 
core structures of MNV and FCV VPg. The amide region of the 
1D 1H NMR spectra of (A) MNV VPg 1-124 and (B) FCV VPg 
1-111. In each case the region of the spectrum shown is the 
structured amide region  of a 1D protein spectrum, which is not 
overlapped by aromatic signals. The peaks at 10.0-10.3 ppm derive 
from the NHε of Trp side chains. 
it stimulate RNA synthesis, while Y45A was associated with 
an intermediate level of activity (Fig. 7). Intriguingly, mutant 
Y40F, which is more stable than Y40A, had close to wild-type 
activity for VPg-enhanced RNA synthesis and for the 
production of the VPg-RNA, whereas introduction of Y45F, 
which does not significantly perturb the core structure 
(Fig. 6A), surprisingly rendered VPg defective for these 
activities. Finally, although the mutants R32D and D48R 
should both lack the salt bridge between α-helices, R32D had 
wild-type activity in the two assays,  while mutant D48R 
mutant was completely inactive (Fig. 7). The effect of the 
R32D/D48R double-mutation could not be determined since 
the resultant protein was not expressed in transfected cells 
(data not shown). 
A defect in the ability of MNV VPg to interact with the 
polymerase should result in decreased production of RNA 
synthesized using VPg as a primer. To examine whether this 
was the case, a electrophoretic mobility shift assay was 
performed using immunoprecipitation of the VPg protein and 
subsequent detection of VPg and VPg-linked RNA via 
Western blotting (44, 71). Previous work had shown that the 
generation of VPg-linked RNA is critically dependent on the 
addition of RNA and VPg and the presence of the MNV 
RdRp (44). Consistent with the effect on RNA synthesis by 
the RdRp, the VPg mutants D23A, E25A, Y26A, Y26F, 
D27A, F29A, Y40A, Y45F, and D48R were all defective for 
production of VPg-RNA (Fig. 7). Overall, these results show 
that a large number of changes in the core of the MNV VPg 
prevented proper activity. However, mutations that 
destabilized the core protein in vitro did not always abolish 
VPg activity (e.g. R32D, Y40F; Table 2).
Effect of destabilising mutations in VPg on FCV and 
MNV infectivity — In an effort to shed further light on the 
significance of the structured core within VPg we also 
introduced destabilising mutations into the virus genome 
using reverse genetics (see Materials and Methods). For 
MNV, live virus could not be recovered from cDNA clones 
carrying the Y40A or Y45A mutants in VPg, both of which 
significantly destabilise the protein core (Table 2). However, 
mutations associated with lesser destabilisation gave variable 
virus yields. For example, although the Y45F mutation is less 
destabilising than Y40F, transcripts containing the Y45F 
substitution yielded no virus, whereas wild-type levels of 
virus were recovered from cDNA clones carrying the Y40F 
mutation,  a result that parallels the findings from the activity 
assays (Fig. 7). The partially destabilising R32D and D48R 
VPg mutations and the R32D/D48R double mutation all 
produced live virus. In the case of D48R the yield of the 
recovered virus was similar to that of wild type (although 
notably this mutation eliminated nucleotidylation activity in 
cell-based assays [Fig. 7]), while for the R32D and the R32D/
D48R mutants the recovered virus had a 10-fold lower yield 
24 hours post transfection (Table 2). Oddly, the levels of viral 
infectivity recovered for R32D and D48R are inversely 
correlated with the effects of these mutations on the ability of 
MNV VPg to enhance polymerase activity in our assay 
(Fig. 7). 
In contrast to the results obtained with MNV, no live virus 
was recovered from the FCV reverse genetics system for any 
of the VPg destabilisation mutations tested (F43A, R47E, 
F62A and R69E) (Table 3).  This suggests that the FCV core 
domain may play a more integral role in the FCV life cycle 
than its MNV counterpart. However,  the possibility that some 
Leen	  et	  al.	  	   Structures	  of	  Calicivirus	  VPg	  proteins
J.	  Virol.	  (2013)	  Volume	  87	  Number	  10	   	   9
or all of these FCV VPg residues have functions in virus 
replication that are independent of the stability of the VPg 
core structure cannot yet be excluded.  
Discussion
In this paper we report the first high-resolution structural 
analysis of calicivirus VPg proteins. These structures are 
surprising in several ways. We find that the VPg proteins of 
FCV and MNV contain α-helical cores flanked by long 
unstructured termini,  in contrast to the intrinsically disordered 
nature of smaller picornavirus VPg (48) and the larger VPg 
proteins from RNA viruses of plants such as potyvirus (53, 
54). Although there is some evidence (from circular 
dichroism measurements, protease sensitivity assays and 
NMR analyses) for the presence of a compact domain within 
potyvirus VPg, a defined tertiary structure has not been 
detected; rather the core within this protein appears to have 
the properties of a dynamic molten globule (54). 
These new observations for calicivirus VPg proteins 
emphasise the structural diversity within this broad grouping 
of VPg proteins, which likely also reflects their different 
functions. While the VPgs of picornaviruses, caliciviruses and 
potyviruses all have a role in viral replication by serving as a 
protein primer for the initiation of RNA synthesis,  their 
additional functions vary (55, 72). Calicivirus VPgs are 
known to be critical for the initiation of viral protein synthesis 
(26), by recruiting host cell initiation factors to the viral RNA 
(35-37). In contrast, the short ~22 amino-acid VPg from 
picornaviruses is not involved in translation initiation; instead 
this function is assumed by an elaborate RNA structure, the 
internal ribosome entry site (IRES), within the 5´-untranslated 
region of the viral genome (72).  Potyvirus VPg is different 
again; although the potyvirus RNA genome also contains an 
IRES that is required for translation initiation (55), its VPg 
protein makes an interaction with the eukaryotic initiation 
factor eIF4E that is critical for infection (38, 40). However,  it 
is not yet clear whether this interaction is needed to initiate 
translation; it may alternatively serve to suppress host-cell 
protein synthesis (73). More recent data have revealed 
interactions between potyvirus VPg (or its precursors) with 
other components of the translation initiation machinery such 
as PABP, eIF4G and eIF4A that may be functionally 
important (reviewed in (55)).
There are clear differences between the VPg structures for 
MNV and FCV. While the VPg core from the vesivirus FCV 
has a three-helix bundle, the murine norovirus VPg core 
contains just the first two helices of this structure (Fig. 2, 4). 
Strikingly, despite significant structural variation, the 
hydrophobic core residues in helix α1 and helix α2 of FCV 
VPg are largely conserved in the MNV structure: residues 
L21, F29, Y40, I42, Y45 and L46 of MNV VPg overlay 
closely with L19, W27, L38, V40, F43 and L44 of FCV VPg 
respectively (Fig. 4C, D). Given that FCV and MNV are 
representative members of the two major clades that 
caliciviruses can be divided into on the basis of VPg 
nucleotide sequences (74), the structures reported should 
serve as useful models for other calicivirus VPg proteins; in 
particular, helices α1 and α2 are likely to be conserved 
features. 
Aside from the helix content,  one of the most notable 
differences between FCV and MNV VPg occurs within the 
sequence of helix 2. In FCV VPg the helix α2 sequence 
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Figure 7: Effects of  mutations on MNV VPg on RNA synthesis by MNV NS7pol. The bar graph shows results from the cell-based 
reporter assay detecting NS7pol products by the RIG-I innate immune receptor. Each bar contains the results from 3 independent  transfected 
HEK293T cells and the results are expressed as a ratio of the firefly (FF) luciferase driven by the IFN-β  promoter relative to a constitutive 
Renilla luciferase (Ren Luc) that was co-expressed within the same cells. Within the bar graph, the solid line represents  reporter levels from 
the NS7pol in the absence of co-expressed VPg. The dashed line denotes the background reporter levels in the absence of RNA synthesis by 
the NS7pol.  Bars identified with asterisks denote results that are statistically  different (p < 0.05) from those of the polymerase alone. Under 
the graph is  a schematic representation of key features within the MNV VPg molecule.  The thick lines  represent the two α-helices in the 
core, the bold Nuc denotes the location of the nucleotidylation tyrosine. The tyrosines that form a hydrophobic region within  the core are 
identified by black diamonds.  The salt-bridge between residues  R32 and D48 is  indicated by a dashed line.  The gel images above the 
graph are from Western blots of immunoprecipitated VPg in cultures tested in parallel to  the reporter assay. The identities of VPg and the 
fraction of the VPg molecules  used by the NS7pol for RNA synthesis  are shown to the left of the images. All samples were from one 
experiment, but cropped to allow alignment of the Western blot results to those of the reporter assay. 
40VEDFLMLRHRAAL52 is replaced in the MNV protein by 
42IDDYLADREREEELL56 (Fig. 3A), which contains many 
more charged residues. Whereas in FCV VPg hydrophobic 
residues on one flank of this helix,  notably L46 and A50, 
make apolar contacts with helix α3, the equivalent residues in 
MNV VPg (D48 and E52) are polar and contribute rather to 
electrostatic stabilisation between helices α2 and α1 (Fig. 4E).  
An important common feature of calicivirus VPg proteins is 
the conserved acid-rich motif (E/DEYDEΩ where Ω denotes 
F, Y or W) that contains the Tyr residue nucleotidylated by the 
viral NS7 polymerase to form primers for RNA synthesis 
(72). Our results for FCV and MNV VPg reveal that this 
motif is found in a conserved location, embedded within the 
first helix of the structure core such that the Tyr side-chain 
points away from the core (Fig.  4C).  Remarkably, despite 
this exposed position, modelling studies suggest that the 
structure of the core would prevent the Tyr from binding close 
enough to the active site of NS7pol to be nucleotidylated by 
the enzyme (Fig. 8). 
To probe how the observed structure relates to function we 
examined the effects of VPg mutations on MNV infectivity, 
and on the VPg-NS7pol interaction using both a cell-based 
assay that reported the VPg-mediated stimulation of 
polymerase activity and an EMSA assay to monitor the 
production of VPg-RNA (44,  71). Some care needs to be 
taken in the comparison of results from these assays because 
of the significant differences in their methodologies. First, it 
is important to appreciate that the two assays have very 
different dynamic ranges. The infectivity assay can detect 
differences in MNV plaque formation over several logs, while 
the two assays for VPg-NS7pol interaction have a range of 
only a few fold. Second, the modulatory effects of VPg on 
RNA synthesis in the reporter assay rely on RIG-I detection 
of RNA synthesized by NS7pol,  followed by signal 
transduction leading to the activation of the IFN-β promoter. 
Thus, the readout is an indirect assessment of RNA synthesis 
by NS7pol and the NS7pol-VPg interaction. 
However, even with these caveats in mind, we believe that 
results from these assays are relevant for understanding how 
VPg structure impacts the functions of the protein. It is 
notable that the majority of the results from the infectivity 
assay agreed with those from the interaction assays: mutations 
that impaired the functional interaction of VPg with NS7pol 
generally abrogated infectivity (Table 2).  Exceptionally, 
within the VPg N-terminal tail, mutants K3A and L21A 
retained interaction with NS7pol, but were not infectious in the 
context of the MNV replicon.  It is possible that residue K3 
and L21 mediate other activities of the VPg required for 
MNV infectivity,  such as RNA encapsidation or modulation 
of translation initiation. The effects of the D48R mutant in the 
infectivity assay and the NS7pol-VPg interaction assays are 
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Wild-­‐type +++ + + +
N-­‐term.	  tail
K3A -­‐ + + ND
K5A ++ + + ND
K7A ++ + + ND
L21A -­‐ + + ND
α-­‐helix	  1
D23A -­‐ -­‐ -­‐ ND
E25A -­‐ -­‐ -­‐ ND
Y26A/Fe -­‐ -­‐ -­‐ +
D27A + -­‐ -­‐ ND
E28A -­‐ -­‐ -­‐ ND
F29A -­‐ -­‐ -­‐ -­‐
R32D ++ + + -­‐/+
Loop
R36D ++ + + ND
Y40A -­‐ -­‐ -­‐ -­‐
Y40F +++ + + +/-­‐
S41A +++ + + ND
α-­‐helix	  2
D43A +++ + + ND
Y45A	   -­‐ -­‐/+ + -­‐
Y45F -­‐ -­‐ -­‐ +
D48R +++ -­‐ -­‐ +/-­‐
R32D/	  D48R ++ ND ND +/-­‐
C-­‐term.	  tail
V115A ++ + + ND
D116A ++ + + ND
Y117F +++ + + ND
aRecovery	   is	  expressed	  as	  the	   yield	  post	   transfec]on	  rela]ve	   to	  wild-­‐type	   (+
++)	   as	   assayed	   by	   >3	   independent	   experiments.	  Typical	   yields	   of	   wild-­‐type	  
virus	   were	   1-­‐5	   x	   104	   TCID50	   units.	   -­‐	   no	  virus	   detected,	   +	   up	   to	   100	  TCID50	  
detected,	  ++	  	  up	  to	  1000	  TCID50,	  +++	  up	  to	  WT	  levels	  of	  virus	  detected.
bEnhancement	   of	   RNA	   synthesis	   by	   the	   NS7pol	   in	   the	   luciferase	   reporter	  
assay	   is	  denoted	   as	  a	   plus	  (+)	  when	   the	   luciferase	   reporters	   are	   sta]s]cally	  
above	   the	   signal	   from	  NS7pol	   expressed	  without	  VPg	   at	   a	  p	  value	  of	  >0.05	  in	  
the	  Student	  t-­‐test.	  
cVPg	  nucleo]dyla]on	  is	  derived	  from	  the	  Western	  blots	  in	  Fig.	  7.	  
dVPg	   core	   stability	   was	  assessed	  from	  1H	   NMR	   shi}	   data	   in	   Fig.	  6A.	  The	  WT	  
VPg	  core	   contains	  nine	  dis]nct	  peaks	  and	  samples	  with	  8	  or	  more	  peaks	  are	  
denoted	  with	  a	   +.	   	  Samples	  with	   three	   to	  ﬁve	   peaks	  are	   denoted	  with	  a	   +/-­‐,	  
and	   samples	   with	   less	   than	   three	   peaks	   are	   denoted	   with	   a	   –.	   ND:	   not	  
determined.	  
eInfec]vity	  data	  for	  Y26F;	  other	  assay	  data	  are	  for	  Y26A.
Table	  3:	  Eﬀect	  of	  muta]ons	  in	  FCV	  VPg	  on	  virus	  infec]vity











aRecovery	   is	  expressed	  as	  yield	   24	  hours	  post	  transfec]on	  rela]ve	   to	  wild-­‐
type	   (+++)	   as	   assayed	   by	   >3	   independent	   experiments.	   Typical	   yields	   of	  
wild-­‐type	  virus	  were	  1-­‐5	  x	  104	  TCID50	   units.	  -­‐	  no	  virus	  detected,	  +	  up	  to	  100	  
TCID50	   detected,	   ++	   	   up	   to	   1000	   TCID50,	   +++	   up	   to	   WT	   levels	   of	   virus	  
detected.	  
more difficult to explain, given that this mutant apparently 
retained wild-type infectivity but was unable to interact with 
the viral polymerase. We can only speculate that the 
interactions within the more elaborate RNA replication 
complexes that form in infected cells might suppress the 
observed defect in the interaction of NS7pol and VPg detected 
by our assays. 
By analogy with results for FMDV 3Dpol,  which is 
structurally very similar to MNV NS7pol (Fig. 8A, B; RMSD 
in backbone Cα positions of 3.9 Å) and binds FMDV VPg in 
an extended polypeptide conformation that positions the 
nucleotidylated Tyr (Tyr3) within the polymerase active site 
(75), we reasoned that the calicivirus VPg core would have to 
unfold to allow the nucleotide acceptor Tyr within helix α1 to 
adopt a similarly extended conformation. This hypothesis 
appeared to be consistent with observations that mutation of 
three Tyr residues in HuNV VPg (Y30A, Y41A, Y46A), all of 
which we would expect to destabilise the core of the protein, 
enhanced the nucleotidylation of the protein in in vitro assays 
(43). However, although alanine substitution of the equivalent 
residues in MNV VPg (F29,  Y40, Y45) were confirmed to 
destabilise the protein core by NMR analysis (Fig. 6, Table 2), 
these mutations generally impaired the interaction with the 
polymerase — although the effects for Y45A were relatively 
Figure 8: How does MNV VPg interact with its polymerase? 
Comparison of the structures of polymerases  and VPg proteins 
from MNV and FMDV. (A) Crystal structure of MNV NS7pol (69) 
and solution structure of MNV VPg 11-85 (this work). The active 
site of the polymerase, where nucleotidylation takes place, is 
coloured blue. It is not yet  clear what conformational changes are 
required for MNV VPg to be accommodated within the active site. 
(B) Co-crystal structure of FMDV 3Dpol and VPg (75), with VPg 
also shown extracted from the structure on the right (for ease of 
comparison with panel A). Only residues  1-15 of FMDV VPg were 
visible in the crystal structure. 
modest. The Y40F mutation, which resulted in a less 
destabilized VPg core structure,  showed evidence of good 
interaction with NS7pol and wild-type infectivity. Together, 
these finding would appear to suggest that the stability of the 
VPg core structure contributes to VPg function.
However, a counter-point to this interpretation is the 
observation that the Y45F mutation, which preserves the core 
structure, appeared to completely abrogate interaction with 
the polymerase and virus infectivity.  It may be that Y45 has 
an important function beyond stabilisation of the VPg core. 
Alternatively, the Y45F substitution may actually enhance the 
stability of the VPg core, which could impair its ability to 
interact functionally with the polymerase, assuming that 
interaction requires at least partial unfolding of the tertiary 
structure (see below). Finally, mutation R32D that should 
disrupt formation of the salt bridge between the two core α-
helices within MNV VPg did not impair infectivity (Table 2, 
Fig. 7).  Collectively our results are consistent with the notion 
that the two-helix core structure of MNV VPg represents a 
finely-balanced state of the VPg structure that may undergo 
modest conformational changes to participate in 
nucleotidylation by NS7pol and successful viral infection. 
Manual docking trials with MNV VPg into the crystal 
structure of the MNV NS7pol (Fig. 8) suggest that, with minor 
side-chain adjustments, there may be room in the substrate-
binding channel to accommodate helix α1 in such a way that 
the Tyr 26 acceptor is positioned in the active site, but only if 
this helix is detached from the VPg core. Alternatively, if the 
VPg core structure remains intact upon binding to the 
polymerase, the thumb and fingers domains of NS7pol would 
have to move apart to accommodate VPg in a productive 
complex. A proper test of these ideas awaits the determination 
of a structure of an NS7pol-VPg complex.  Until that time, the 
definition of the boundaries between structured and 
unstructured domains of the FCV and MNV VPg proteins and 
the fold of the structured cores reported here provide an 
improved framework for the design of mutagenesis 
experiments to continue probing VPg function. 
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